Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
coenzyme Q10 + magnesium + riboflavin + feverfew + skullcap + piperine
- Development stage
- Unknown
- Lead developer
- Wellena
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
This combination is a multi-ingredient dietary supplement formulated for the prophylaxis of migraines and the management of chronic headaches. It integrates mitochondrial bioenergetic support agents, such as Coenzyme Q10 and Riboflavin (Vitamin B2), with Magnesium to address metabolic deficiencies and neuronal hyperexcitability associated with migraine pathophysiology. The formula includes botanical extracts: Feverfew (Tanacetum parthenium), which contains parthenolide to inhibit NF-kappaB signaling and pro-inflammatory cytokine production, and American Skullcap (Scutellaria lateriflora), traditionally used for its anxiolytic and neuroprotective effects via GABAergic modulation. Piperine is included as a bioavailability enhancer to optimize the intestinal absorption of Coenzyme Q10 and other phytochemical components.
- Brand names
- Migra-Well
- Other names
- MigraWell
02
Targets
ND1 (Mitochondrial electron transport chain complex I)GABRR (GABA-A receptor subunit rho)NMDAR (Glutamate receptor ionotropic, NMDA)IKBKB (IKKβ)RFK (Riboflavin kinase)
Beyond the preview
Go deeper on coenzyme Q10 + magnesium + riboflavin + feverfew + skullcap + piperine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on coenzyme Q10 + magnesium + riboflavin + feverfew + skullcap + piperine.